Huaren Pharmaceutical announced on the evening of June 2 that Huaren Century Group, the shareholder of the company, which holds 7.9% of the company's shares, plans to reduce its holdings by no more than 1% of the company's total share capital through centralized bidding transactions, that is, no more than 11.822,100 shares.

Huaren Pharmaceutical announced on the evening of June 2 that Huaren Century Group, the shareholder of the company, which holds 7.9% of the company's shares, plans to reduce its holdings by no more than 1% of the company's total share capital through centralized bidding transactions, that is, no more than 11.822,100 shares.